Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival
Open Access
- 3 July 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 98 (14), 7952-7957
- https://doi.org/10.1073/pnas.151241198
Abstract
We present a general method for rigorously identifying correlations between variations in large-scale molecular profiles and outcomes and apply it to chromosomal comparative genomic hybridization data from a set of 52 breast tumors. We identify two loci where copy number abnormalities are correlated with poor survival outcome (gain at 8q24 and loss at 9q13). We also identify a relationship between abnormalities at two loci and the mutational status of p53. Gain at 8q24 and loss at 5q15-5q21 are linked with mutant p53. The 9q and 5q losses suggest the possibility of gene products involved in breast cancer progression. The analytical techniques are general and also are applicable to the analysis of array-based expression data.Keywords
This publication has 15 references indexed in Scilit:
- Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.2001
- High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarraysNature Genetics, 1998
- Molecular cytogenetics of primary breast cancer by CGH.1998
- Probing lymphocyte biology by genomic-scale gene expression analysis.Journal of Clinical Immunology, 1998
- Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patientsNature Medicine, 1996
- Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Alterations of the TP53 Gene as a Potential Prognostic Marker in Breast CarcinomasDiagnostic Molecular Pathology, 1995
- Computer image analysis of comparative genomic hybridizationCytometry, 1995
- Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.Molecular and Cellular Biology, 1994
- In Vivo Amplification and Rearrangement of c-myc Oncogene in Human Breast TumorsJNCI Journal of the National Cancer Institute, 1988